History | Elosulfase alfa for treating mucopolysaccharidosis type 4A | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 162 KB)

Published:

20 April 2022

Final evaluation determination

Final evaluation determination
Public committee slides (PDF 1.02 MB)

Published:

21 March 2022
Committee papers (PDF 3.88 MB)

Published:

21 March 2022
Final evaluation determination document (PDF 324 KB)

Published:

21 March 2022

Evaluation consultation

Evaluation consultation
Evaluation consultation document (PDF 321 KB)

Published:

12 November 2021
Public committee slides (PDF 1.47 MB)

Published:

12 November 2021
Committee papers (PDF 8.66 MB)

Published:

12 November 2021
Evaluation consultation document (Online commenting)

Invitation to participate

Final scope (PDF 167 KB)

Published:

13 December 2019
Final stakeholder list (PDF 185 KB)

Published:

13 December 2019
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 460 KB)

Published:

13 December 2019
Equality Impact Assessment (Guidance development) (PDF 131 KB)

Published:

13 December 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft matrix post referral (PDF 185 KB)

Published:

15 November 2019
Draft scope post referral (PDF 173 KB)

Published:

15 November 2019